Nova Eye Medical Limited (ASX:EYE)
Australia
· Delayed Price · Currency is AUD 0.1300
+0.0100 (8.33%)
May 9, 2025, 4:10 PM AEST
Nova Eye Medical Revenue
Nova Eye Medical had revenue of 12.93M AUD in the half year ending December 31, 2024, with 54.05% growth. This brings the company's revenue in the last twelve months to 26.11M, up 39.08% year-over-year. In the fiscal year ending June 30, 2024, Nova Eye Medical had annual revenue of 23.33M with 37.00% growth.
Revenue (ttm)
26.11M
Revenue Growth
+39.08%
P/S Ratio
1.41
Revenue / Employee
86.75K
Employees
301
Market Cap
36.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 23.33M | 6.30M | 37.00% |
| Jun 30, 2023 | 17.03M | 3.65M | 27.26% |
| Jun 30, 2022 | 13.38M | -16.00K | -0.12% |
| Jun 30, 2021 | 13.39M | 578.00K | 4.51% |
| Jun 30, 2020 | 12.82M | -3.32M | -20.59% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |